D M Barnes

5.1k citations

41 papers · 4.3k indexed · 2 hit papers · h-index 26

Impact in

Oncology top 1%
- Cancer-related Molecular Pathways
- HER2/EGFR in Cancer Research
Cancer Research top 2%
- Cancer Genomics and Diagnostics
- Breast Cancer Treatment Studies

Papers in

Oncology 29
- Cancer-related Molecular Pathways 17
- HER2/EGFR in Cancer Research 10
Cancer Research 14
- Breast Cancer Treatment Studies 8
- Cancer Genomics and Diagnostics 6

Co-authors: Cheryl Gillett David P. Lane David A. Levison C. C.‐W. Yu Richard S. Camplejohn C. Fisher R. Dover Amanda L. Woods
Journals: British Journal of Cancer (8 papers)The Journal of Pathology (6 papers)European Journal of Cancer (4 papers)The Breast (2 papers)Molecular Pathology (2 papers)
Partner nations: United Kingdom United States Netherlands

In The Last Decade

D M Barnes

40 papers receiving 4.2k citations

Hit Papers

align trajectories log scale

Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining. 1994 · 589 citations

Peers

Countries citing papers authored by D M Barnes

Since Specialization

Citations

This map shows the geographic impact of D M Barnes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D M Barnes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D M Barnes more than expected).

Fields of papers citing papers by D M Barnes

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D M Barnes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D M Barnes. The network helps show where D M Barnes may publish in the future.

Co-authorship network

The 25 scholars most cited alongside D M Barnes, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with D M Barnes Line = papers co-authored together D M Barnes links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Peripheral and central nervous system inhibition of 11β-hydroxysteroid dehydrogenase type 1 in man by the novel inhibitor ABT-384 Translational Psychiatry ·David A. Katz, Shivaji R. Gunale, C. Locke, Peer B. Jacobson, D M Barnes, Rita Basu, Guohua An, Matthew J. Rieser, 曹汉礼, Frank D. Groves, A. M. Klicheva, Chumpitaz Dino, Hakop Gevorkyan, Stanford S. Jhee, Larry Ereshefsky, Gerard J. Marek	2013	12
2	The interaction of oestrogen receptor status and pathological features with adjuvant treatment in relation to survival in patients with operable breast cancer: a retrospective study of 2660 patients. Endocrine Related Cancer ·D M Barnes, R R Millis, C E Gillett, Ken Ryder, Jenny Begin, Ian S. Fentiman, R.D. Rubens	2004	24
3	BAG‐1 expression in human breast cancer: interrelationship between BAG‐1 RNA, protein, HSC70 expression and clinico‐pathological data The Journal of Pathology ·Paul A. Townsend, E Dublin, Ian R. Hart, A. Bray, A M Hanby, Ramsey Cutress, Richard Poulsom, K W Ryder, D M Barnes, Graham Packham	2002	41
4	Investigations on a clinically and functionally unusual and novel germline p53 mutation British Journal of Cancer ·Julian C. Rutherford, Carol Chu, 日下喬史, Ruth Charlton, Paul Chumas, Graham R. Taylor, Xin Lü, D M Barnes, Richard S. Camplejohn	2002	16
5	Mitotic counts provide additional prognostic information in grade II mammary carcinoma The Journal of Pathology ·Jill E. Lynch, Yuichi OKAZAKI, D M Barnes, A M Hanby, Richard S. Camplejohn, K W Ryder, Cheryl Gillett	2002	11
6	Retention of the expression of E-cadherin and catenins is associated with shorter survival in grade III ductal carcinoma of the breast The Journal of Pathology ·Cheryl Gillett, D.W. Miles, K W Ryder, Jenny Begin, Mônica Pereira Coelho, R. J. Springall, D M Barnes, A M Hanby	2001	84
7	Multiple tissue core arrays in histopathology research: a validation study The Journal of Pathology ·Cheryl Gillett, R. J. Springall, D M Barnes, A M Hanby	2000	101
8	Increased use of immunohistochemistry for oestrogen receptor measurement in mammary carcinoma: the need for quality assurance European Journal of Cancer ·D M Barnes, Rosemary R. Millis, L.V.A.M. Beex, S.M. Thorpe, Robin Leake	1998	69
9	Tumour grade does not change between primary and recurrent mammary carcinoma European Journal of Cancer ·Rosemary R. Millis, D M Barnes, Ain Nur Afifa Baharudin, Jennifer Zink, Paul Smith	1998	38
10	Demystified ... cell cycle. Molecular Pathology ·Cheryl Gillett, D M Barnes	1998	34
11	Characterization of p53 oligomerization domain mutations isolated from Li–Fraumeni and Li–Fraumeni like family members Oncogene ·Martine E. Lomax, D M Barnes, Ted R. Hupp, Steven M. Picksley, RS Camplejohn	1998	88
12	Two functional assays employed to detect an unusual mutation in the oligomerisation domain of p53 in a Li-Fraumeni like family Oncogene ·Martine E. Lomax, D M Barnes, R Gilchrist, Steven M. Picksley, J M Varley, RS Camplejohn	1997	54
13	Determination of cell proliferation Molecular Pathology ·D M Barnes, C E Gillett	1995	21
14	Amplification of chromosome band 11q13 and a role for cyclin D1 in human breast cancer Cancer Letters ·Clive Dickson, Vera Fantl, Cheryl Gillett, Sharon Brookes, Jiří Bártek, Daron Smith, C. Fisher, D M Barnes, Godefridus J. Peters	1995	152
15	Heterogeneity in Li-Fraumeni families: p53 mutation analysis and immunohistochemical staining. Journal of Medical Genetics ·C. MacGeoch, G. S. Turner, L. G. Bobrow, D M Barnes, D. Timothy Bishop, Nigel K. Spurr	1995	15
16	p53 immunoreactivity in human malignant melanoma and dysplastic naevi British Journal of Dermatology ·J.M. McGregor, C. C.‐W. Yu, E Dublin, D M Barnes, David A. Levison, D.M. MACDONALD	1993	58
17	Overexpression of the c-erbB-2 oncoprotein: Why does this occur more frequently in ductal carcinoma in situ than in invasive mammary carcinoma and is this of prognostic significance? European Journal of Cancer ·D M Barnes, Tereza Kapinusová, Giyos Abduvoxidov, Jiřina Bártková, RS Camplejohn, William J. Gullick	1992	98
18	Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: An index of cell proliferation with evidence of deregulated expression in some, neoplasms The Journal of Pathology ·Peter A. Hall, David A. Levison, Amanda L. Woods, C. C.‐W. Yu, Alexei Barchukov, Johnathan Watkins, D M Barnes, Cheryl Gillett, Richard S. Camplejohn, R. Dover, Naushin Waseem, David P. Lane Hit paper breakdown →	1990	1299
19	Breast cancer and a proto-oncogene. BMJ ·D M Barnes	1989	31
20	An immunohistochemical study of the presence of c‐erbB‐2 protein in Paget's disease of the nipple Histopathology ·G A Lammie, D M Barnes, R R Millis, WJ Gullick	1989	71

About D M Barnes

D M Barnes is a scholar working on Oncology, Cancer Research, Biotechnology, Pathology and Forensic Medicine and Genetics, having authored 41 papers that have together received 4.3k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (17 papers), HER2/EGFR in Cancer Research (10 papers), Breast Cancer Treatment Studies (8 papers), Estrogen and related hormone effects (6 papers), Cancer Genomics and Diagnostics (6 papers), Cancer Research and Treatments (5 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Epigenetics and DNA Methylation (3 papers). The work is most often cited by research in Oncology (2.3k citations), Cancer Research (958 citations), Biotechnology (301 citations), Pathology and Forensic Medicine (593 citations) and Molecular Biology (2.0k citations). D M Barnes has collaborated with scholars based in United Kingdom, United States and Netherlands. Frequent co-authors include Cheryl Gillett, David P. Lane, David A. Levison, C. C.‐W. Yu, Richard S. Camplejohn, C. Fisher, R. Dover, Amanda L. Woods, Peter A. Hall and Johnathan Watkins. Their work appears in journals such as British Journal of Cancer, The Journal of Pathology, European Journal of Cancer, The Breast and Molecular Pathology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact